Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe

NCT01424891 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT01424891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01424891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe
Lead sponsor
Heidelberg University
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2004
Completion date
August 31, 2011
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation, type 2 diabetes